ilmscore | Prediction Details
"from 22 to 23 the revenue grow at 11 from 23 to 24 the revenue grow at 13"
By CA Rachana Phadke Ranade | January 22, 2025 | Pending
From video
Mankind Pharma: Fundamental Analysis | Stocks in Focus - Part 3 | CA Rachana Ranade 00:08:17 - 00:08:22
Interpreted Prediction
Mankind Pharma experienced revenue growth of 11% in FY23 and 13% in FY24.

Prediction Details

Ticker
MANKIND

Comments

0 comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.